Fogelholm R, Eskola K, Kiminkinen T, Kunnamo I
Department of Neurology, Central Hospital of Central Finland, Jyväskyläa.
J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1121-4. doi: 10.1136/jnnp.55.12.1121.
Forty one (14.2%) of 288 patients with primary intracerebral haemorrhage occurring between September 1985 and December 1989 in Central Finland were on anticoagulant treatment at the onset of symptoms. In a sample of 29,000 subjects from the same population the prevalence of anticoagulant treatment was 1.6% in those aged 40 years or older. The estimated age adjusted odds ratio of being on anticoagulant treatment at the time of primary intracerebral haemorrhage was 6.7 (95% CI from 4.5 to 9.9). The risk was highest during the first year of anticoagulation. Overtreatment (thrombotest value < 5%) was slightly more common among the patients. The haematoma volumes measured from the CT scans were similar in patients on anticoagulant treatment and those not anticoagulated. The case fatality rate during the first week and the mortality during follow up of 32 months were slightly higher, and the functional outcome slightly worse in the anticoagulated group.
1985年9月至1989年12月期间,芬兰中部288例原发性脑出血患者中,有41例(14.2%)在症状出现时正在接受抗凝治疗。在来自同一人群的29000名受试者样本中,40岁及以上人群的抗凝治疗患病率为1.6%。经年龄调整后,原发性脑出血时接受抗凝治疗的估计比值比为6.7(95%可信区间为4.5至9.9)。抗凝治疗的第一年风险最高。患者中过度治疗(凝血试验值<5%)略为常见。接受抗凝治疗的患者与未接受抗凝治疗的患者相比,CT扫描测量的血肿体积相似。抗凝组第一周的病死率和32个月随访期间的死亡率略高,功能结局略差。